drugset / Trial / NCT02694718
A Study of Capecitabine Plus Oxaliplatin in Combination With Pre-operative Pelvic Radiotherapy in Rectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the pathological complete tumor response rate.
Timeline
- Start
- 2005-03
- Primary completion
- 2006-08
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 825 mg/m2 | Oral |
| Subject | Oxaliplatin | Small molecule | 50 mg/m2 | Intravenous |